Literature DB >> 18018930

Missing the forest: further thoughts on the ethics of bystander risk in medical research.

Jonathan Kimmelman1.   

Abstract

Mesh：

Year:  2007        PMID： 18018930     DOI： 10.1017/s0963180107070648

Source DB:  PubMed          Journal:  Camb Q Healthc Ethics        ISSN： 0963-1801            Impact factor:   1.284


× No keyword cloud information.
  5 in total

Review 1.  Regulating impact on bystanders in clinical trials: An unsettled frontier.

Authors:  Nir Eyal; Jonathan Kimmelman; Lisa G Holtzman; Marc Lipsitch
Journal:  Clin Trials       Date:  2019-08-01       Impact factor: 2.486

2.  Using, risking, and consent: Why risking harm to bystanders is morally different from risking harm to research subjects.

Authors:  Alec Walen
Journal:  Bioethics       Date:  2020-04-07       Impact factor: 1.898

3.  Bystanders, risks, and consent.

Authors:  Helen Frowe
Journal:  Bioethics       Date:  2019-10-25       Impact factor: 1.898

4.  Minimal or reasonable? Considering the ethical threshold for research risks to nonconsenting bystanders and implications for nonconsenting participants.

Authors:  Holly Fernandez Lynch
Journal:  Bioethics       Date:  2020-02-24       Impact factor: 1.898

5.  Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field.

Authors:  Leili Fatehi; Susan M Wolf; Jeffrey McCullough; Ralph Hall; Frances Lawrenz; Jeffrey P Kahn; Cortney Jones; Stephen A Campbell; Rebecca S Dresser; Arthur G Erdman; Christy L Haynes; Robert A Hoerr; Linda F Hogle; Moira A Keane; George Khushf; Nancy M P King; Efrosini Kokkoli; Gary Marchant; Andrew D Maynard; Martin Philbert; Gurumurthy Ramachandran; Ronald A Siegel; Samuel Wickline
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.